FDA approves Atebrioz for rare bone disease fibrodysplasia ossificans progressiva
FDA approves Atebrioz for rare bone disease fibrodysplasia ossificans progressiva
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
FDA approves Atebrioz for rare bone disease fibrodysplasia ossificans progressiva
Korea’s trade surplus hits a record $23B. Here’s what’s driving it
TikTok settles with Alabama ahead of first state trial over claims of teen harms
Americans navigate ’wild West’ of health insurance options after dropping Obamacare plans
Subway, soccer and spats: New York’s Mamdani a UN week attraction
Analysis-How Trump’s diplomatic week exposed the limits of his power
Rush of money, campaign stops show Republicans feel vulnerable in Iowa, Kansas
Cypherpunk technologies director Oei Khing Djien sells $661,500 in stock
US lawmakers aim to keep China’s datacenter tech out of sensitive government systems
The long-anticipated exit of the commissioner sometimes known as Crypto Mom is Oct. 2, announced as the agency was sending out its latest crypto work.
Kodiak Sciences to report phase 3 trial results Monday
Venezuela’s promised elections face long delays, sources say
Marygold Companies to be taken private by Madison Dearborn Partners in all-cash deal
Ibotta CTO Luke Swanson sells $661,216 of IBTA shares
CDW completes acquisition of data and AI firm Lovelytics
Tidewater enters guarantee agreement for BNDES construction loans
Don’t look now, but there are some technical reasons to believe that U.S. Treasury Secretary Scott Bessent was right when he declared to the financial markets that “I am the house now.”
Paramount Skydance to move stock listing to NYSE from Nasdaq
Marygold Companies enters agreement to go private in deal with Madison Dearborn
Moody’s cuts Botswana credit rating to Baa2, shifts outlook to stable
News text belongs to its source; only the headline and a short summary appear here.